Broadfin Capital’s TearLab Corporation TEAR Stock Holding History

Broadfin Capital’s Portfolio TEAR Stock Details TEAR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-91,450	Closed	-$1.85M	–	102
2015 Q2	$1.85M	Hold	91,450	–	–	0.1%	90
2015 Q1	$1.82M	Buy	+91,450	New	+$2.2M	0.14%	75

Other funds holding TEAR

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

Altrinsic Global Advisors Stamford, Connecticut $2.79B AUM 7.25% 1-Year Est. Return

Cortina Asset Management Milwaukee, Wisconsin $1.62B AUM 15.44% 1-Year Est. Return

Chilton Investment Company Stamford, Connecticut $4.26B AUM 1.32% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wall Street Associates Lajolla, California $151M AUM 30.3% 1-Year Est. Return

Glacier Peak Capital Bellevue, Washington $96.2M AUM 0.45% 1-Year Est. Return

Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Massachusetts Financial Services

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Potomac Capital Management New York $115M AUM

Broadfin Capital's TEAR Position: Q3 2015 in Review

Broadfin Capital sold out of TearLab Corporation (TEAR) in Q3 2015, closing a stake of 91,450 shares — an estimated $1.85M sold.

Broadfin Capital first reported a position in TEAR in Q1 2015 and held it in 2 quarters. The position peaked at $1.85M in Q2 2015. 42 funds tracked by Wall St. Rank hold TEAR as of Q3 2015.

Broadfin Capital reported no remaining TearLab Corporation position as of Q3 2015 after selling out during the quarter.
Broadfin Capital sold 91,450 TearLab Corporation shares in Q3 2015, an estimated $1.85M.
Broadfin Capital first reported a position in TearLab Corporation in Q1 2015 and held it in 2 quarters.
Broadfin Capital's TearLab Corporation position peaked at $1.85M in Q2 2015.
42 funds tracked by Wall St. Rank held TearLab Corporation as of Q3 2015.

Based on Broadfin Capital's 13F filing for Q3 2015, filed 16 Nov 2015.